Case Series

Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus Azacitidine

Zhang LS, Wang J, Xu MZ, Wu TM, Huang SM, Cao HY, Sun AN, Liu SB, Xue SL

OncoTargets and Therapy 2022, 15:159-164

Published Date: 18 February 2022